Medtronic Inc. (MDT): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Medtronic ( MDT) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 1.8%. By the end of trading, Medtronic rose $0.96 (1.6%) to $59.26 on average volume. Throughout the day, 7,122,563 shares of Medtronic exchanged hands as compared to its average daily volume of 4,926,400 shares. The stock ranged in a price between $58.26-$59.80 after having opened the day at $58.27 as compared to the previous trading day's close of $58.30. Other companies within the Health Care sector that increased today were: Flexion Therapeutics ( FLXN), up 11.8%, Cormedix ( CRMD), up 10.7%, Iridex Corporation ( IRIX), up 9.2% and Cara Therapeutics ( CARA), up 8.8%.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. Medtronic has a market cap of $57.7 billion and is part of the health services industry. Shares are up 1.6% year to date as of the close of trading on Thursday. Currently there are 9 analysts that rate Medtronic a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, reasonable valuation levels, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Endologix ( ELGX), down 24.4%, Compugen ( CGEN), down 20.1%, Medivation ( MDVN), down 14.9% and Kindred Biosciences ( KIN), down 14.6% , were all laggards within the health care sector with Actavis ( ACT) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

More from Markets

Is Best Buy Sleeping With the Enemy With Amazon Partnership?

Is Best Buy Sleeping With the Enemy With Amazon Partnership?

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

Sprint, T-Mobile Might Have to Do More Than Make Promises to Get Deal Approved

Video: The S&P 500 Is Failing to Make New Highs

Video: The S&P 500 Is Failing to Make New Highs

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump

Dow, S&P 500 and Nasdaq Finish Lower as Apple, P&G Slump

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists